$5 Million Ebola Vaccine Deal Agreed to; Aims to Prevent Outbreaks
Global vaccine alliance Gavi announced today that they’d provide the funds to develop Merck & Co.’s VSV-EBOV vaccine, to combat potential future Ebola outbreaks. The $5 million U.S. deal for the experimental vaccine, originally developed in Canada, still needs the…
Read more
